Clinical Trials Sponsored by Biotech Dental

Total 11120 results

Krystal Biotech, Inc.

Active, not recruiting

Topical Beremagene Geperpavec (KB103) Gene Therapy to Restore Functional Collagen VII for the Treatment of Dystrophic Epidermolysis Bullosa (GEM-1)

Dystrophic Epidermolysis Bullosa

United States
Cook Biotech Incorporated

Completed

Treatment of Wounds Using Oasis® ECM

Non-healing Wound

United Kingdom
NKGen Biotech, Inc.

Withdrawn

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Sarcoma | Cervical Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | EGF-R Positive Non-Small... and other conditions
Metagone Biotech Inc.

Completed

Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid Tumor

Solid Tumor

Taiwan
Galecto Biotech AB

Completed

A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Safety and Tolerability

United Kingdom
Marinomed Biotech AG

Completed

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Austria
Moleculin Biotech, Inc.

Completed

Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Poland
Shanghai Henlius Biotech

Withdrawn

Evaluate the Efficacy and Safety of HLX01 Versus Mabthera in Patients With Low Tumour Burden Follicular Lymphoma.

CD20-positive Follicular Lymphoma, With Low Tumour Burden
Steba Biotech S.A.

Withdrawn

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Localized Prostate Cancer

United States
HOB Biotech Group

Withdrawn

Clinical Performance of BioCLIA Ro60

Systemic Lupus Erythematosus | Sjogren's Syndrome

United States
NKGen Biotech, Inc.

Completed

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

Plaque Psoriasis

Mexico
Archigen Biotech Limited

Completed

PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Korea, Republic of, Hungary, Poland, Czechia, Spain, Bosnia and Herzegovina, Bulgaria, Germany, India, Mexico
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Sweden
JHL Biotech, Inc.

Terminated

A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis

Arthritis, Rheumatoid | Rheumatoid Arthritis

Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Lithuania, Poland, Russian Federation, Taiwan, Ukraine, United Kingdom
JHL Biotech, Inc.

Completed

A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects

Healthy Subjects

Netherlands
PCI Biotech AS

Completed

A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

Cholangiocarcinoma

Germany, France, Norway, United Kingdom
PCI Biotech AS

Completed

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Healthy Volunteer

United Kingdom
Steba Biotech S.A.

Completed

Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. (PCM301)

Prostate Cancer

Spain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
PCI Biotech AS

Completed

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

Head and Neck Neoplasms | Skin Neoplasms

United Kingdom
ASIT Biotech S.A.

Unknown

Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever
Steba Biotech S.A.

Terminated

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Macular Degeneration | Choroidal Neovascularization

United States, France
SciVision Biotech Inc.

Completed

The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain

Osteoarthritis, Knee
Fertility Biotech AG

Completed

Comparative Pharmacokinetics of AFOLIA and US Gonal-f® RFF Redi-ject After Single Subcutaneous Application

Healthy Volunteers

United Kingdom
ZZ Biotech, LLC

Completed

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of 3K3A-APC in Healthy Adult Volunteers

Healthy

Austria
GenMont Biotech Incorporation

Completed

Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients

Type 2 Diabetes

Taiwan
Andromeda Biotech Ltd.

Completed

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults (DIA-AID2)

Type 1 Diabetes Mellitus

United States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
SciVision Biotech Inc.

Withdrawn

Safety and Efficacy Study of Lidocaine Mixed Hyaluronate on Nasolabial Folds Correction

Pain | Nasolabial Folds Correction

Taiwan
Steba Biotech S.A.

Terminated

Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

Cholangiocarcinoma

France
Folia Biotech Inc.

Unknown

Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults

Flu

Canada
Siena Biotech S.p.A.

Completed

A Phase II Safety and Tolerability Study With SEN0014196

Huntington's Disease

Germany
Janssen Biotech, Inc.

Completed

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

United States
Steba Biotech S.A.

Completed

Study Using WST11 in Patients With Localized Prostate Cancer

Prostate Cancer

Netherlands, France, United Kingdom
Active Biotech AB

Completed

ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Denmark, Russian Federation
Mentrik Biotech, LLC

Unknown

Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies

Previously Treated CD20+ B-cell Malignancies

United States
Andromeda Biotech Ltd.

Completed

Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes

Type 1 Diabetes

Israel
Facet Biotech
Biogen

Terminated

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Peritoneal Neoplasms | Ovarian Cancer

United States, Canada
Lorenz Biotech S.p.A.

Completed

Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy

Diabetic Neuropathy, Painful

France, Germany, Italy
Olympus Biotech Corporation

Completed

OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions

Tibial Nonunions

United States
Olympus Biotech Corporation

Completed

OP-1 Putty for Posterolateral Fusions

Degenerative Lumbar Spondylolisthesis

United States, Canada
Cura Biotech LLC

Unknown

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

Osteoarthritis | Rheumatoid Arthritis

United States
Welichem Biotech Inc.

Completed

Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis (WBI-1001-101)

Psoriasis

Canada
BioNTech US Inc.

Recruiting

NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma

Metastatic Melanoma | Unresectable Melanoma

Belgium, Netherlands, Spain
Central Institute of Mental Health, Mannheim

Not yet recruiting

Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption (NeuStress)

Craving | Alcohol Abuse | Psychosocial Stressor | Neural Stress Response

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder (A03)

Risk Behavior | Alcohol Use Disorder | Craving | Relapse | Stress Reaction | Social Stress | Addiction, Alcohol

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Selective Attention in Alcohol Use Disorder

Alcohol Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Electroconvulsive Therapy for Treatment of Alzheimer´s Disease (ECTAD)

Alzheimer's Disease
Central Institute of Mental Health, Mannheim

Completed

Evaluation of the Addictive Potential of E-Cigarettes (EVAPE)

Tobacco Use Disorder | Nicotine Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Amitriptyline and Paroxetine Treatment of Major Depression

Unipolar Depression

Germany
Central Institute of Mental Health, Mannheim

Completed

Modification of Goal-directed and Habitual Behavior in Addiction

Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Investigation of Brain Oxygenation and Blood Flow in Smokers (OEF)

Cerebral Oxygenation and Blood Flow in Tobacco Use Disorder

Germany

Clinical Trials Sponsored by Biotech Dental

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations